ARCA biopharma submits IND application to US FDA for a potential COVID-19 treatment
Pending FDA feedback, ARCA anticipates initiating the Phase 2b portion of a sequential Phase 2b/3 clinical evaluation of AB201 in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
anti-viral drug
Glenmark to launch FabiFlu (400 mg) for COVID-19 treatment
With the new 400 mg version, patients need to consume nine tablets on Day 1, and thereafter two tablets twice a day from Day 2…
Mylan gets approval to make and market remdesivir
Jubilant, BDR and Dr Reddy's Labs have also awaiting permission from CDSCO to manufacture and market the drug in India and are…
Gilead seeks marketing authorisation from CDSCO for remdesivir
The medicine has been issued EUA by the US FDA to treat hospitalised coronavirus patients
US FDA issues EUA for remdesivir for COVID-19 treatment
The EUA allows for remdesivir to be distributed in the US and administered intravenously by healthcare providers, as appropriate,…